Image

Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit

Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Patients admitted for polytrauma, severe neurological injury, post-operative monitoring or sepsis/septic shock present with significant inflammation, leading to immunoparalysis, which is responsible for infection, particularly prolonged infection. A study of their lymphocyte phenotype over time could help explore the phenomenon of immunoparalysis.

Eligibility

Inclusion criteria:

  • Postoperative esophagectomy surveillance within the last 24 hours.
  • Patients with intra-abdominal infection
  • Neurological patients with intubation planned for more than 24 hours (subarachnoid hemorrhage with coma, severe head trauma, ischemic or hemorrhagic stroke with coma).
  • Polytrauma with intubation planned for more than 24 hours
  • Patient aged 18 and over
  • Patient with social security coverage

Non-inclusion criteria :

  • Hereditary immune deficiency HIV-AIDS
  • Malignant hemopathies
  • Immunosuppressive treatment other than corticosteroid therapy or chemotherapy
  • Patient under legal protection
  • Pregnant or breast-feeding women

Study details
    Patients Undergoing Esophagectomy
    Patients with Severe Polytrauma
    Patients with Severe Neurological Lesion
    Patients with Abdominal Infection

NCT06415474

University Hospital, Brest

9 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.